ENTA Historical PE Ratio image   This ENTA PE ratio history page last updated 8/10/2022
ENTA Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
8/8/2022
71.27-1.53-6.12NA
Q2 2022
5/9/2022
52.93-1.63-6.52NA
Q1 2022
2/8/2022
61.18-1.48-5.92NA
Q4 2021
11/22/2021
75.18-1.22-4.88NA
Q3 2021
8/5/2021
46.25-1.19-4.76NA
Q2 2021
5/6/2021
51.00-1.09-4.36NA
Q1 2021
2/8/2021
54.95-0.41-1.64NA
Q4 2020
11/23/2020
43.67-1.46-5.84NA
Q3 2020
8/4/2020
47.69-0.71-2.84NA
Q2 2020
5/6/2020
51.67-0.30-1.20NA
Q1 2020
2/6/2020
55.620.652.6021.4
Q4 2019
11/21/2019
63.510.441.7636.1
Q3 2019
8/6/2019
70.830.331.3253.7
Q2 2019
5/7/2019
87.590.200.80109.5
Q1 2019
2/6/2019
83.801.255.0016.8
Q4 2018
11/26/2018
81.911.305.2015.8
Q3 2018
8/7/2018
91.760.973.8823.6
Q2 2018
5/8/2018
105.570.612.4443.3
Q1 2018
2/7/2018
89.060.783.1228.5
Q4 2017
11/20/2017
49.711.867.446.7
Q3 2017
8/7/2017
38.50-0.44-1.76NA
Q2 2017
5/8/2017
30.81-0.28-1.12NA
Q1 2017
2/8/2017
31.17-0.26-1.04NA
Q4 2016
11/21/2016
30.07-0.09-0.36NA
Q3 2016
8/8/2016
21.71-0.06-0.24NA
Q2 2016
5/9/2016
25.45-0.09-0.36NA
Q1 2016
2/8/2016
21.521.365.444.0
Q4 2015
11/23/2015
31.880.291.1627.5
Q3 2015
8/6/2015
46.430.130.5289.3
Q2 2015
5/7/2015
33.721.495.965.7
Q1 2015
2/5/2015
35.172.188.724.0
Q4 2014
11/24/2014
45.21-0.27-1.08NA
Q3 2014
8/11/2014
38.472.6110.443.7
Q2 2014
5/12/2014
34.78-0.28-1.12NA
Q1 2014
2/13/2014
38.18-0.30-1.20NA
Q4 2013
11/25/2013
24.84-0.25-1.00NA
Q3 2013
8/12/2013
18.87-0.23-0.92NA
Q2 2013
5/8/2013
20.07-2.28-9.12NA
ENTA PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
8/8/2022
71.27-1.53-5.86NA
Q2 2022
5/9/2022
52.93-1.63-5.52NA
Q1 2022
2/8/2022
61.18-1.48-4.98NA
Q4 2021
11/22/2021
75.18-1.22-3.91NA
Q3 2021
8/5/2021
46.25-1.19-4.15NA
Q2 2021
5/6/2021
51.00-1.09-3.67NA
Q1 2021
2/8/2021
54.95-0.41-2.88NA
Q4 2020
11/23/2020
43.67-1.46-1.82NA
Q3 2020
8/4/2020
47.69-0.710.08>500
Q2 2020
5/6/2020
51.67-0.301.1246.1
Q1 2020
2/6/2020
55.620.651.6234.3
Q4 2019
11/21/2019
63.510.442.2228.6
Q3 2019
8/6/2019
70.830.333.0823.0
Q2 2019
5/7/2019
87.590.203.7223.5
Q1 2019
2/6/2019
83.801.254.1320.3
Q4 2018
11/26/2018
81.911.303.6622.4
Q3 2018
8/7/2018
91.760.974.2221.7
Q2 2018
5/8/2018
105.570.612.8137.6
Q1 2018
2/7/2018
89.060.781.9246.4
Q4 2017
11/20/2017
49.711.860.8856.5
Q3 2017
8/7/2017
38.50-0.44-1.07NA
Q2 2017
5/8/2017
30.81-0.28-0.69NA
Q1 2017
2/8/2017
31.17-0.26-0.50NA
Q4 2016
11/21/2016
30.07-0.091.1226.8
Q3 2016
8/8/2016
21.71-0.061.5014.5
Q2 2016
5/9/2016
25.45-0.091.6915.1
Q1 2016
2/8/2016
21.521.363.276.6
Q4 2015
11/23/2015
31.880.294.097.8
Q3 2015
8/6/2015
46.430.133.5313.2
Q2 2015
5/7/2015
33.721.496.015.6
Q1 2015
2/5/2015
35.172.184.248.3
Q4 2014
11/24/2014
45.21-0.271.7625.7
Q3 2014
8/11/2014
38.472.611.7821.6
Q2 2014
5/12/2014
34.78-0.28-1.06NA
Q1 2014
2/13/2014
38.18-0.30-3.06NA
Q4 2013
11/25/2013
24.84-0.25NANA
Q3 2013
8/12/2013
18.87-0.23NANA
Q2 2013
5/8/2013
20.07-2.28NANA
Quotes delayed 20 minutes

Email EnvelopeFree ENTA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Enanta Pharmaceuticals (ENTA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ENVB PE Ratio History
ENZ PE Ratio History
EOLS PE Ratio History
EPZM PE Ratio History
EQ PE Ratio History
ERAS PE Ratio History
ESPR PE Ratio History
ETNB PE Ratio History
ETON PE Ratio History
ETTX PE Ratio History
How should the ENTA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Enanta Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ENTA Historical PE Ratio page.

What is the average historical PE for ENTA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ENTA historical PE ratio using the annualized quarterly earnings method works out to 30.6.

What is the average historical PE for ENTA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ENTA historical PE ratio using the TTM earnings method works out to 24.1.

On this page we presented the ENTA Historical PE Ratio information for Enanta Pharmaceuticals' stock. The average ENTA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 30.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ENTA historical PE based on this TTM earnings result method is 24.1. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ENTA historical PE result, against the recent PE: when this page was posted on 8/9/2022, the most recent closing price for ENTA had been 68.27, and the most recent quarterly earnings result, annualized, was 2.6. Meanwhile, the most recent TTM earnings summed to 0.08. From these numbers, we calculate the recent ENTA PE on 8/9/2022 based on annualized quarterly EPS was 26.3. Based on ENTA's history, that recent PE is low relative to the historical average, with the recent PE 14.1% lower than the historical average PE across our data set for Enanta Pharmaceuticals. Looking at the recent ENTA PE on 8/9/2022 based on TTM EPS, we calculate the ratio at 853.4. Based on ENTA's history, that recent PE is elevated relative to the historical average, with the recent PE 3441.1% higher than the historical average PE across our Enanta Pharmaceuticals data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ENTA or any other given stock, valuation analysis for ENTA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Enanta Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ENTA. Thanks for visiting, and the next time you need to research ENTA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: FUL market cap history, BFIT shares outstanding history, HA Videos.

 

ENTA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.